Fibrinogen concentrate does not suppress endogenous fibrinogen synthesis in a 24-hour porcine trauma model

Anesthesiology

Volumn 121, Issue 4, 2014, Pages 753-764

  Zentai, Christian ^a   Braunschweig, Till ^a   Schnabel, Jonas ^a   Rose, Michael ^a   Rossaint, Rolf ^a   Grottke, Oliver ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; BLUNT TRAUMA; DISEASE MODEL; HUMAN; LIVER; MALE; METABOLISM; RANDOMIZATION; SWINE; TIME;

ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOGEN; HUMANS; LIVER; MALE; RANDOM ALLOCATION; SWINE; TIME FACTORS; WOUNDS, NONPENETRATING;

EID: 84914177993     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000315     Document Type: Article

References (47)

1. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tønnesen E, Ingerslev J, Sørensen B: Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: A randomized, placebo-controlled clinical trial. J Thromb Haemost 2009; 7:795-802.
2. Schöchl H, Schlimp CJ: Trauma bleeding management: The concept of goal-directed primary care. Anesth Analg 2013 [Epub ahead of print].
3. Sørensen B, Tang M, Larsen OH, Laursen PN, Fenger-Eriksen C, Rea CJ: The role of fibrinogen: A new paradigm in the treatment of coagulopathic bleeding. Thromb Res 2011; 128(suppl 1):S13-6.
4. Solomon C, Rahe-Meyer N, Sørensen B: Fibrin formation is more impaired than thrombin generation and platelets immediately following cardiac surgery. Thromb Res 2011; 128:277-82.
5. Kind SL, Spahn-Nett GH, Emmert MY, Eismon J, Seifert B, Spahn DR, Theusinger OM: Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates? Anesth Analg 2013; 117:1063-71.
6. Schlimp CJ, Cadamuro J, Solomon C, Redl H, Schöchl H: The effect of fibrinogen concentrate and factor XIII on thromboelastometry in 33% diluted blood with albumin, gelatine, hydroxyethyl starch or saline in vitro. Blood Transfus 2013; 11:510-7.
7. Spahn DR: Severe bleeding in surgical and trauma patients: The role of fibrinogen replacement therapy. Thromb Res 2012; 130(suppl 2):S15-9.
8. de Bosch NB, Mosesson MW, Ruiz-Sáez A, Echenagucia M, Rodriguez-Lemoin A: Inhibition of thrombin generation in plasma by fibrin formation (Antithrombin I). Thromb Haemost 2002; 88:253-8.
9. Mosesson MW: Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation. Thromb Haemost 2003; 89:9-12.
10. Dickneite G, Pragst I, Joch C, Bergman GE: Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen concentrate (Haemocomplettan P). Blood Coagul Fibrinolysis 2009; 20:535-40.
11. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258:1183-6.
12. Peters SA, Woodward M, Rumley A, Koenig W, Tunstall-Pedoe H, Lowe GD: Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all-causes mortality: The Scottish Heart Health Extended Cohort. Br J Haematol 2013; 162:392-9.
13. Meyer MA, Ostrowski SR, Windeløv NA, Johansson PI: Fibrinogen concentrates for bleeding trauma patients: What is the evidence? Vox Sang 2011; 101:185-90.
14. Ozier Y, Hunt BJ: Against: Fibrinogen concentrate for management of bleeding: Against indiscriminate use. J Thromb Haemost 2011; 9:6-8.
15. Stanworth SJ, Hunt BJ: The desperate need for good-quality clinical trials to evaluate the optimal source and dose of fibrinogen in managing bleeding. Crit Care 2011; 15:1006.
16. Karlsson M, Ternström L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A: Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost 2009; 102:137-44.
17. Solomon C, Hagl C, Rahe-Meyer N: Time course of haemostatic effects of fibrinogen concentrate administration in aortic surgery. Br J Anaesth 2013; 110:947-56.
18. Kreuz W, Meili E, Peter-Salonen K, Dobrkovská A, Devay J, Haertel S, Krzensk U, Egbring R: Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus Apher Sci 2005; 32:239-46.
19. Grottke O, Braunschweig T, Philippen B, Gatzweiler KH, Gronloh N, Staat M, Rossaint R, Tolba R: A new model for blunt liver injuries in the swine. Eur Surg Res 2010; 44:65-73.
20. Schlimp CJ, Solomon C, Hochleitner G, Zipperle J, Redl H, Schöchl H: Thromboelastometric maximum clot firmness in platelet-free plasma is influenced by the assay used. Anesth Analg 2013; 117:23-9.
21. Velik-Salchner C, Schnürer C, Fries D, Müssigang PR, Moser PL, Streif W, Kolbitsch C, Lorenz IH: Normal values for thrombelastography (ROTEM) and selected coagulation parameters in porcine blood. Thromb Res 2006; 117:597-602.
22. Fink L, Seeger W, Ermert L, Hänze J, Stahl U, Grimminger F, Kummer W, Bohle RM: Real-time quantitative RT-PCR after laser-assisted cell picking. Nat Med 1998; 4:1329-33.
23. Grottke O, Braunschweig T, Spronk HM, Esch S, Rieg AD, van Oerle R, ten Cate H, Fitzner C, Tolba R, Rossaint R: Increasing concentrations of prothrombin complex concentrate induce disseminated intravascular coagulation in a pig model of coagulopathy with blunt liver injury. Blood 2011; 118:1943-51.
24. Birch HE, Schreiber G: Transcriptional regulation of plasma protein synthesis during inflammation. J Biol Chem 1986; 261:8077-80.
25. Fuller GM, Otto JM, Woloski BM, McGary CT, Adams MA: The effects of hepatocyte stimulating factor on fibrinogen biosynthesis in hepatocyte monolayers. J Cell Biol 1985; 101:1481-6.
26. Spahn DR, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernández-Mondéjar E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer E, Ozier Y, Riddez L, Schultz A, Vincent JL, Rossaint R: Management of bleeding and coagulopathy following major trauma: An updated European guideline. Crit Care 2013; 17:R76.
27. Thompson GH, Florentino-Pineda I, Armstrong DG, Poe-Kochert C: Fibrinogen levels following Amicar in surgery for idiopathic scoliosis. Spine (Phila Pa 1976) 2007; 32:368-72.
28. Wei KL, Lin CJ, Lai KA: Changes in coagulatory profile after orthopedic surgery. J Formos Med Assoc 1995; 94:541-7.
29. Schreiber MA, Differding J, Thorborg P, Mayberry JC, Mullins RJ: Hypercoagulability is most prevalent early after injury and in female patients. J Trauma 2005; 58:475-80.
30. Martini J, Cabrales P, Fries D, Intaglietta M, Tsai AG: Effects of fibrinogen concentrate after shock/resuscitation: A comparison between in vivo microvascular clot formation and thromboelastometry∗. Crit Care Med 2013; 41:e301-8.
31. Martini J, Maisch S, Pilshofer L, Streif W, Martini W, Fries D: Fibrinogen concentrate in dilutional coagulopathy: A dose study in pigs. Transfusion 2014; 54:149-57.
32. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA: Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: An in vitro model. Br J Anaesth 2009; 102:793-9.
33. Dempfle CE, Kälsch T, Elmas E, Suvajac N, Lücke T, Münch E, Borggrefe M: Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots. Blood Coagul Fibrinolysis 2008; 19:765-70.
34. Rahe-Meyer N, Solomon C, Hanke A, Schmidt DS, Knoerzer D, Hochleitner G, Sørensen B, Hagl C, Pichlmaier M: Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: A randomized, placebo-controlled trial. Anesthesiology 2013; 118:40-50.
35. Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C: Goaldirected coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14:R55.
36. Solomon C, Cadamuro J, Ziegler B, Schöchl H, Varvenne M, Sørensen B, Hochleitner G, Rahe-Meyer N: A comparison of fibrinogen measurement methods with fibrin clot elasticity assessed by thromboelastometry, before and after administration of fibrinogen concentrate in cardiac surgery patients. Transfusion 2011; 51:1695-706.
37. Huissoud C, Carrabin N, Audibert F, Levrat A, Massignon D, Berland M, Rudigoz RC: Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 2009; 116:1097-102.
38. Davenport R, Manson J, De'Ath H, Platton S, Coates A, Allard S, Hart D, Pearse R, Pasi KJ, MacCallum P, Stanworth S, Brohi K: Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39:2652-8.
39. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K: Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10:1342-51.
40. Schöchl H, Schlimp CJ, Voelckel W: Potential value of pharmacological protocols in trauma. Curr Opin Anaesthesiol 2013; 26:221-9.
41. Kalina U, Stöhr HA, Bickhard H, Knaub S, Siboni SM, Mannucci PM, Peyvandi F: Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency. Blood Coagul Fibrinolysis 2008; 19:777-83.
42. Grottke O, Braunschweig T, Henzler D, Coburn M, Tolba R, Rossaint R: Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 2010; 14:R62.
43. Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V, Haas T, Innerhofer P: Effect of fibrinogen on reversal of dilutional coagulopathy: A porcine model. Br J Anaesth 2005; 95:172-7.
44. Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, Koppert W, Rahe-Meyer N: Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth 2010; 104:555-62.
45. Tanaka KA, Taketomi T, Szlam F, Calatzis A, Levy JH: Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P). Anesth Analg 2008; 106:732-8.
46. Jennings I, Kitchen DP, Woods T, Kitchen S, Walker ID: Differences between multifibrin U and conventional Clauss fibrinogen assays: Data from UK National External Quality Assessment Scheme surveys. Blood Coagul Fibrinolysis 2009; 20:388-90.
47. Setiabudy R, Silman E: External quality assessment scheme for blood coagulation. Southeast Asian J Trop Med Public Health 2002; 33(suppl 2):94-8.